PRKG1 and hearing loss disorder: Manipulation of cGMP levels and activation of PKG by activating ANP and receptor signals represent a potential therapeutic approach to support SGN survival as well as enhance regeneration and regrowth of SGN neurites, which promise to be a fruitful area for developing new and effective therapies for hearing impairment.